Author Description

Research on 5-hydroxytryptamine (5-HT) has exploded over the past decade and nowhere have the implications been more far-reaching than in psychiatry. Through the introduction of radioligand binding techniques, a bewildering variety of central 5-HT receptors has been revealed, and powerful new families of centrally active drugs have emerged. For example, our understanding of and the treatment for obsessive-compulsive disorder has been transformed in a very few years. This book is the result of a meeting of the Collegium Internationale Neuro-Psychopharmacologicum. Its free-ranging cut and thrust and the many good ideas presented cannot fail to be of interest to neuroscientists, pharmacologists, psychiatrists, and all those who wish to keep abreast of this rapidly moving area of research.